ArticleScientific reports2021

Erythromycin reduces nasal inflammation by inhibiting immunoglobulin production, attenuating mucus secretion, and modulating cytokine expression.

Ting-Ting Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.